|
PCID2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64712687933388E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05599973210246E-11 |
| Normal-vs-Stage2 |
1.00259999968877E-07 |
| Normal-vs-Stage3 |
1.65678581964812E-12 |
| Normal-vs-Stage4 |
2.68496336275348E-12 |
| Stage1-vs-Stage2 |
1.937570E-01 |
| Stage1-vs-Stage3 |
1.205800E-02 |
| Stage1-vs-Stage4 |
1.428110E-02 |
| Stage2-vs-Stage3 |
6.470200E-01 |
| Stage2-vs-Stage4 |
4.389800E-01 |
| Stage3-vs-Stage4 |
6.624200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.43689570931383E-15 |
| Normal-vs-AfricanAmerican |
2.17999999999607E-05 |
| Normal-vs-Asian |
2.67840000001129E-06 |
| Caucasian-vs-AfricanAmerican |
4.829400E-01 |
| Caucasian-vs-Asian |
7.506400E-02 |
| AfricanAmerican-vs-Asian |
5.753400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64657176782157E-12 |
| Normal-vs-Female |
1.82120984959511E-12 |
| Male-vs-Female |
1.462830E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.13690193212801E-11 |
| Normal-vs-Age(41-60Yrs) |
5.78292969066752E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-15 |
| Normal-vs-Age(81-100Yrs) |
1.73869999997578E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.559000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.061000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.074230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.619840E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.160800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.056000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.079000E-03 |
| Classical-VS-Follicular |
5.556000E-01 |
| Classical-VS-Other |
9.366600E-01 |
| Classical-VS-Normal |
1.71149761030165E-11 |
| Tall-VS-Follicular |
5.009600E-02 |
| Tall-VS-Other |
3.613800E-01 |
| Tall-VS-Normal |
5.87474513480402E-12 |
| Follicular-VS-Other |
9.005000E-01 |
| Follicular-VS-Normal |
2.99379999679772E-08 |
| Other-VS-Normal |
5.797700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.14106510298961E-12 |
| Normal-vs-N1 |
1.12889697589935E-11 |
| N0-vs-N1 |
1.441010E-01 |
|
|
